The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer.
 
Manabu Muto
Speakers' Bureau - Canon Medical System; Chugai Pharma; Daiichi Sankyo/Lilly; Illumina; Incyte Japan; Merck; MSD; Novartis; Olympus; Ono Pharmaceutical; Shionogi
Research Funding - Canon Medical System; Chugai Pharma; H.U. Group Holdings; Meiji Seika Kaisha; NTT; NTT Data; Taiho Pharmaceutical
 
Keiko Minashi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); BeiGene (Inst); Daiichi Sankyo/UCB Japan (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Tomonori Yano
No Relationships to Disclose
 
Yusuke Amanuma
No Relationships to Disclose
 
Ryu Ishihara
No Relationships to Disclose
 
Akinori Watanabe
No Relationships to Disclose
 
Chikatoshi Katada
No Relationships to Disclose
 
Tomoki Yamatsuji
No Relationships to Disclose
 
Kayoko Matsushima
No Relationships to Disclose
 
Hisashi Doyama
No Relationships to Disclose
 
Takayuki Ando
Honoraria - Bristol-Myers Squibb Company; DAIICHI SANKYO COMPANY, LIMITED.; Lilly Japan; Merck; Miyarisan pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED. (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Yasumasa Nishimura
No Relationships to Disclose
 
Katsuyuki Sakanaka
No Relationships to Disclose
 
Shigeru Tsunoda
Honoraria - Abbott Japan; Asahi Kasei; Covidien/Medtronic; Ethicon/Johnson & Johnson; Kaken Pharmaceutical; Miyarisan Pharmaceutical
 
Shinya Ohashi
No Relationships to Disclose
 
Juko Shimizu
No Relationships to Disclose
 
Harue Tada
No Relationships to Disclose
 
Ryuji Uozumi
Consulting or Advisory Role - CAC Croit Corporation; Eisai; EPS Corporation; Sawai Pharmaceutical Co
 
Kengo Nagashima
Consulting or Advisory Role - Fujimoto; Kowa; Senju Pharmaceutical; Toray Industries
 
Hiroki Sasaki
No Relationships to Disclose